Biomark Diagnostics Revenue and Competitors

Richmond, BC

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Biomark Diagnostics's estimated annual revenue is currently $542.5k per year.(i)
  • Biomark Diagnostics's estimated revenue per employee is $77,500

Employee Data

  • Biomark Diagnostics has 7 Employees.(i)
  • Biomark Diagnostics grew their employee count by 75% last year.

Biomark Diagnostics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.1M4018%$40MN/A
#2
$0.2M20%N/AN/A
#3
$1.3M17-15%N/AN/A
#4
$2.6M176%N/AN/A
#5
$12.9M835%N/AN/A
#6
$1.9M244%$89.5MN/A
#7
$2.8M186%N/AN/A
#8
$40.3M26021%N/AN/A
#9
$0.9M60%N/AN/A
#10
$0.6M4-20%N/AN/A
Add Company

What Is Biomark Diagnostics?

BioMark is an oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. We have developed and own multiple intellectual properties (IPs) in detection and quantitation of metabolites. We hand-picked a proven, global enterprise team of scientists, engineers and medical professionals to help commercialize our innovative technology and to increase prediction and accuracy in the diagnosis of cancers by following and incorporating the highest regulatory ,clinical and scientific standards.. Our cross pollinated, balanced and committed team was established in 2007. Our mission is to develop and commercialize innovative technologies to increase prediction and accuracy in diagnosis of cancers.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$542.5k

Revenue (est)

75%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Biomark Diagnostics News

2022-04-19 - Stocks in play: BioMark Diagnostics Inc

... works performed with Quebec-based Phytronix Technologies Inc. BioMark Diagnostics Inc shares C.BUX are trading unchanged at $0.22.

2022-04-19 - 2022-04-27 | CSE:BUX | Press Release | BioMark Diagnostics ...

BioMark to Present New Cancer Screening Data Using the LDTD-MS/MS ... April 27, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M7-22%N/A
#2
$0.5M70%N/A
#3
$0.5M70%N/A
#4
$0.5M7N/AN/A
#5
$0.5M7-71%N/A